Sustainability at Roche

Scroll to learn more

Our approach

For over 120 years Roche has been committed to improving lives. The long-term thinking of our founders has allowed us to stay true to this vision. Our greatest contribution to society is lasting innovation. When acting sustainably, we also aim to provide a rewarding workplace, be a trustworthy partner and engage in the communities we work in and with.

Roche has been recognised as the most sustainable healthcare company in the 2018 Dow Jones Sustainability Indices.

Severin Schwan on sustainability

Severin Schwan, CEO of the Roche Group, on sustainability. "Developing medicines and tests is our main contribution to society."

Reverse mentoring

When senior leaders and junior employees benefit from each other's perspective and share work experiences.

Our impact on society

Innovating for patients

Providing a great workplace

Being a trustworthy partner

Environment and communities

Delivering continuous growth

Innovating for patients

127 million patients

treated with Roche medicines

>20 billion tests

conducted with Roche Diagnostics products

30 Roche medicines

on the WHO Model List of Essential Medicines

Explore our stories

Our reporting

Roche is committed to transparent reporting and we endeavour to drive our economic, social and environmental performance with the same diligence as our financial performance.

External recognition

Our sustainability efforts have been recognised by key ratings such as Dow Jones Sustainability Indices (DJSI) or the Access to Medicine Index (AtMI).

Roche received the Gold Award by RobecoSAM for its excellent sustainability performance. For the tenth consecutive year, Roche has been recognised as the most sustainable company in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI).

Roche ranked 10th in the AtMI in 2018. The Index analyses large research-based healthcare companies on how they make their products more accessible in low- and middle-income countries.